BrightInsight Announces $101M in Series C Funding led by General Catalyst
Similar Posts
Neuroglee Therapeutics Closes Series A Round to Advance Virtual Care and Digital Therapies for Alzheimer’s Disease Treatment in the Home
$10 million funding round led by Openspace Ventures with participation from EDBI will fuel first-in-class virtual neurology clinics Neuroglee…
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines
Curevo’s lead program is CRV-101, an adjuvanted subunit vaccine for shingles, which has demonstrated robust immunogenicity and tolerability in…
Avive Secures $22 Million in Series A Funding to Advance Intelligent AED and Lifesaving Platform for Out-of-Hospital Cardiac Arrest
Deployment of a Novel 4-Minute City Program that Engages Community Members to Speed AED Response Time, Improve Survival…
